Bruker Pre-Tax Profit Margin 2012-2026 | BRKR
Current and historical pre-tax profit margin for Bruker (BRKR) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bruker pre-tax profit margin for the three months ending March 31, 2026 was .
| Bruker Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-03-31 | $3.46B | $0.02B | 0.55% |
| 2025-12-31 | $3.44B | $0.02B | 0.64% |
| 2025-09-30 | $3.44B | $0.01B | 0.29% |
| 2025-06-30 | $3.44B | $0.14B | 3.98% |
| 2025-03-31 | $3.45B | $0.16B | 4.64% |
| 2024-12-31 | $3.37B | $0.21B | 6.15% |
| 2024-09-30 | $3.24B | $0.39B | 12.10% |
| 2024-06-30 | $3.12B | $0.46B | 14.62% |
| 2024-03-31 | $3.00B | $0.51B | 16.99% |
| 2023-12-31 | $2.96B | $0.55B | 18.39% |
| 2023-09-30 | $2.82B | $0.43B | 15.08% |
| 2023-06-30 | $2.71B | $0.44B | 16.03% |
| 2023-03-31 | $2.62B | $0.43B | 16.30% |
| 2022-12-31 | $2.53B | $0.41B | 16.36% |
| 2022-09-30 | $2.51B | $0.41B | 16.49% |
| 2022-06-30 | $2.48B | $0.39B | 15.88% |
| 2022-03-31 | $2.46B | $0.40B | 16.40% |
| 2021-12-31 | $2.42B | $0.39B | 16.29% |
| 2021-09-30 | $2.36B | $0.38B | 16.08% |
| 2021-06-30 | $2.27B | $0.35B | 15.28% |
| 2021-03-31 | $2.12B | $0.30B | 14.02% |
| 2020-12-31 | $1.99B | $0.23B | 11.37% |
| 2020-09-30 | $1.96B | $0.23B | 11.79% |
| 2020-06-30 | $1.97B | $0.24B | 12.13% |
| 2020-03-31 | $2.04B | $0.26B | 12.58% |
| 2019-12-31 | $2.07B | $0.28B | 13.51% |
| 2019-09-30 | $2.03B | $0.27B | 13.28% |
| 2019-06-30 | $1.97B | $0.25B | 12.73% |
| 2019-03-31 | $1.93B | $0.25B | 12.77% |
| 2018-12-31 | $1.90B | $0.24B | 12.86% |
| 2018-09-30 | $1.87B | $0.23B | 12.43% |
| 2018-06-30 | $1.84B | $0.22B | 11.67% |
| 2018-03-31 | $1.81B | $0.20B | 11.14% |
| 2017-12-31 | $1.77B | $0.20B | 11.21% |
| 2017-09-30 | $1.71B | $0.20B | 11.55% |
| 2017-06-30 | $1.66B | $0.19B | 11.60% |
| 2017-03-31 | $1.62B | $0.18B | 11.17% |
| 2016-12-31 | $1.61B | $0.18B | 10.99% |
| 2016-09-30 | $1.62B | $0.16B | 9.64% |
| 2016-06-30 | $1.62B | $0.14B | 8.45% |
| 2016-03-31 | $1.65B | $0.14B | 8.75% |
| 2015-12-31 | $1.62B | $0.13B | 7.88% |
| 2015-09-30 | $1.65B | $0.11B | 6.35% |
| 2015-06-30 | $1.68B | $0.09B | 5.36% |
| 2015-03-31 | $1.74B | $0.10B | 5.64% |
| 2014-12-31 | $1.81B | $0.10B | 5.64% |
| 2014-09-30 | $1.85B | $0.11B | 6.04% |
| 2014-06-30 | $1.87B | $0.13B | 6.94% |
| 2014-03-31 | $1.87B | $0.13B | 7.11% |
| 2013-12-31 | $1.84B | $0.13B | 6.80% |
| 2013-09-30 | $1.80B | $0.11B | 5.88% |
| 2013-06-30 | $1.81B | $0.14B | 7.56% |
| 2013-03-31 | $1.78B | $0.12B | 6.75% |
| 2012-12-31 | $1.79B | $0.14B | 7.76% |
| 2012-09-30 | $1.75B | $0.16B | 8.91% |
| 2012-06-30 | $1.72B | $0.14B | 7.97% |
| 2012-03-31 | $1.70B | $0.15B | 8.88% |
| 2011-12-31 | $1.65B | $0.15B | 8.78% |
| 2011-09-30 | $1.59B | $0.15B | 9.11% |
| 2011-06-30 | $1.48B | $0.14B | 9.70% |
| 2011-03-31 | $1.38B | $0.15B | 10.48% |
| 2010-12-31 | $1.31B | $0.15B | 11.57% |
| 2010-09-30 | $1.26B | $0.17B | 13.71% |
| 2010-06-30 | $1.21B | $0.16B | 13.06% |
| 2010-03-31 | $1.16B | $0.14B | 12.13% |
| 2009-12-31 | $1.12B | $0.13B | 11.48% |
| 2009-09-30 | $1.06B | $0.10B | 9.12% |
| 2009-06-30 | $1.04B | $0.09B | 8.55% |
| 2009-03-31 | $1.10B | $0.10B | 9.45% |
| 2008-12-31 | $1.11B | $0.09B | 8.49% |
| 2008-09-30 | $1.14B | $0.12B | 10.55% |
| 2008-06-30 | $1.14B | $0.14B | 11.87% |
| 2008-03-31 | $1.06B | $0.13B | 11.95% |
| 2007-12-31 | $1.03B | $0.14B | 13.84% |
| 2007-09-30 | $1.24B | $0.17B | 13.56% |
| 2007-06-30 | $1.10B | $0.14B | 12.98% |
| 2007-03-31 | $0.96B | $0.12B | 12.86% |
| 2006-12-31 | $0.85B | $0.11B | 13.04% |
| 2006-09-30 | $0.44B | $0.03B | 7.05% |
| 2006-06-30 | $0.42B | $0.03B | 7.13% |
| 2006-03-31 | $0.39B | $0.03B | 6.63% |
| 2005-12-31 | $0.37B | $0.02B | 5.65% |
| 2005-09-30 | $0.39B | $0.02B | 4.10% |
| 2005-06-30 | $0.37B | $0.01B | 2.43% |
| 2005-03-31 | $0.36B | $0.00B | 0.55% |
| 2004-12-31 | $0.36B | $0.00B | 0.56% |
| 2004-09-30 | $0.27B | $-0.01B | -1.84% |
| 2004-06-30 | $0.27B | $-0.01B | -3.35% |
| 2004-03-31 | $0.27B | $-0.01B | -2.26% |
| 2003-12-31 | $0.26B | $-0.01B | -3.45% |
| 2003-09-30 | $0.30B | $-0.01B | -4.38% |
| 2003-06-30 | $0.29B | $-0.01B | -2.06% |
| 2003-03-31 | $0.26B | $-0.01B | -2.71% |
| 2002-12-31 | $0.22B | $0.00B | -1.81% |
| 2002-09-30 | $0.22B | $0.00B | -0.92% |
| 2002-06-30 | $0.19B | $0.00B | -1.08% |
| 2002-03-31 | $0.18B | $0.00B | 1.68% |
| 2001-12-31 | $0.18B | $0.00B | 1.71% |
| 2001-09-30 | $0.09B | $0.01B | 5.56% |
| 2001-06-30 | $0.09B | $0.01B | 5.62% |
| 2001-03-31 | $0.09B | $0.00B | 4.71% |
| 2000-12-31 | $0.08B | $0.00B | 2.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |